Previous Article | Next Article 
Journal of Bacteriology, September 2000, p. 4803-4810, Vol. 182, No. 17
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Entry into and Release of Solvents by
Escherichia coli in an Organic-Aqueous Two-Liquid-Phase
System and Substrate Specificity of the AcrAB-TolC
Solvent-Extruding Pump
Norihiko
Tsukagoshi and
Rikizo
Aono*
Department of Biological Information,
Graduate School of Bioscience and Biotechnology, Tokyo Institute of
Technology, Nagatsuta 4259, Midori-ku, Yokohama 226-8501, Japan
Received 10 November 1999/Accepted 12 June 2000
 |
ABSTRACT |
Growth of Escherichia coli is inhibited upon exposure
to a large volume of a harmful solvent, and there is an inverse
correlation between the degree of inhibition and the log
POW of the solvent, where
POW is the partition coefficient measured for
the partition equilibrium established between the n-octanol
and water phases. The AcrAB-TolC efflux pump system is involved in
maintaining intrinsic solvent resistance. We inspected the solvent
resistance of
acrAB and/or
tolC mutants
in the presence of a large volume of solvent. Both mutants were
hypersensitive to weakly harmful solvents, such as nonane (log
POW = 5.5). The
tolC mutant
was more sensitive to nonane than the
acrAB mutant. The
solvent entered the E. coli cells rapidly. Entry of
solvents with a log POW higher than 4.4 was
retarded in the parent cells, and the intracellular levels of these
solvents were maintained at low levels. The
tolC mutant accumulated n-nonane or decane (log
POW = 6.0) more abundantly than the parent
or the
acrAB mutant. The AcrAB-TolC complex likely extrudes solvents with a log POW in the range
of 3.4 to 6.0 through a first-order reaction. The most favorable
substrates for the efflux system were considered to be octane, heptane,
and n-hexane.
 |
INTRODUCTION |
There is increasing interest in
culturing microorganisms in two-liquid-phase systems consisting of an
aqueous medium and a hydrophobic organic solvent. This culture system
is potentially advantageous for bioconversion of hydrophobic substrates
with low solubility in water. Hydrophobic organic solvents can be toxic to microorganisms. When microbial cells are exposed to a large volume
of an organic solvent with a log POW of 2 to 5, the solvent binds to the cells (2) and disturbs the
structure of the cell membrane (3, 23). Here, log
POW is the common logarithm of the partition
coefficient (POW) measured for the partition
equilibrium established between the n-octanol and water
phases (10). It has been proposed that solvent toxicity is
inversely correlated with the log POW of a
solvent (6). The extent of the inhibition of growth of
Escherichia coli cells by a solvent in a two-phase culture
system seems to be inversely correlated with the log
POW of the solvent (3).
On the other hand, it is reported that organic solvents with high log
POW values are incorporated into erythrocytes
and phospholipid liposomes more abundantly than those with low log
POW values (15, 23). E. coli cells accumulate solvent in a manner positively dependent on
the log POW and the concentration of the solvent in the medium. The empirical rule that there is an inverse correlation between the toxicity and the log POW of a
solvent can be applied only to culture systems containing a large
volume of solvent. The rule is based on the extent of growth
inhibition, not on the toxicity strength of the solvent.
Several physiological and biochemical approaches have been applied in
an effort to elucidate the mechanisms of microbial resistance to
solvents (24). In recent years, it has been demonstrated that energy-dependent efflux is involved in organic solvent tolerance in gram-negative bacteria (7, 17, 18, 22). Cloned genes coding for components of efflux pumps belonging to the
resistance/nodulation/cell division (RND) family (20) have
been shown to serve to maintain solvent resistance in certain bacteria
(4, 8, 11, 21, 25). Genetic evidence suggests that the
AcrAB-TolC efflux pump, a member of the RND family (5, 14),
is involved in solvent resistance of E. coli cells (4,
25). However, whether the AcrAB-TolC pump actually reduces the
intracellular solvent concentration in E. coli cells exposed
to a solvent remains to be demonstrated. In the present study, we
examined solvent entry into acrAB and tolC
mutants incubated in a two-phase culture system. We found that E. coli cells maintained a constant intracellular level of certain
solvents. The specificity of solvent efflux by the AcrAB-TolC efflux
pump was characterized by monitoring the release of solvents accumulated intracellularly.
In this report, we describe the characteristics of entry of solvent
from the external milieu containing a large volume of the solvent, the
release of intracellular solvent (AcrAB-TolC-dependent and -independent
release), and solvent accumulation in E. coli.
 |
MATERIALS AND METHODS |
Bacterial strains and plasmids.
E. coli K-12
derivatives used to evaluate solvent resistance are summarized in Table
1. acrAB genes were cloned
from strain W3110 [F
IN(rrnD-rrnE)1] (9). DH5
[supE44
lacU169(
80 lacZ
M15)
hsdR17 recA1 endA1 gyrA96 thi-1 relA1] was used as the host
for the construction of plasmids.
The low-copy-number vectors pMW119, pMW218, and pMW219 (GenBank
accession no. AB005476 to 005478) (Nippon Gene, Tokyo, Japan), and the
high-copy-number vector pBluescript II KS(+) (Toyobo Biochemical,
Osaka, Japan) were used. Genes cat and kan were
derived from plasmids pHSG399 (Takara Shyuzo, Osaka, Japan) and pUC4K (Pharmacia Biotech, Uppsala, Sweden), respectively. The
temperature-sensitive plasmid pG+host4 (Appligene, Inc.,
Pleasanton, Calif.) was used to disrupt the acrAB genes in
E. coli JA300.
Culture conditions.
The organisms were grown aerobically at
37°C in LBGMg medium consisting of 1% Bacto Tryptone (Difco
Laboratories, Detroit, Mich.), 0.5% Bacto Yeast Extract (Difco), 1%
NaCl, 0.1% glucose, and 10 mM MgSO4 (1). This
medium was solidified with 1.5% (wt/vol) agar. Ampicillin (50 µg/ml)
or kanamycin (50 µg/ml) was added to the medium when necessary.
Measurement of the organic solvent tolerance levels of E. coli.
Cultures of E. coli strains in LBGMg medium
(optical density at 660 nm [OD660], 0.4 to 0.6) were
diluted with 0.9% saline by serial 10-fold dilutions. Each suspension
was plated on LBGMg agar. The surface of the agar was overlaid with a
3-mm-thick layer of an organic solvent. The approximate frequency at
which the cells formed colonies on the agar was estimated after a 16-h
incubation at 37°C.
Using the log POW calculation software, ClogP
version 4.0 (Bio Byte Corporation, Claremont, Calif.), the log
POW of each organic solvent was calculated by
the addition rule (10).
Determination of the amount of solvent entering bacterial
cells.
Solvent was added to a suspension of E. coli
cells harvested during the late exponential phase of growth
(OD660, 1.5 to 2.0). The suspension was centrifuged 30 min
after addition of the solvent. The solvent layer, separated from the
medium layer, was removed by aspiration. The medium was disposed of by
decanting. The cell pellet was recovered and suspended in 1.5 ml of
0.9% NaCl-10 mM MgSO4. A 0.75-ml portion of the
suspension was then transferred to an Eppendorf tube. The remaining
portion was kept to measure the protein content. The 0.75-ml cell
suspension was extracted with 0.75 ml of CHCl3 by vigorous
shaking for 90 min at 20°C in a shaker (Handless shaker SHK-COCK;
Asahi Technoglass, Tokyo, Japan).
The amount of solvent in the CHCl3 extract was measured
using a gas-liquid chromatography apparatus (GC-9AM; Shimadzu, Kyoto, Japan). A sample of the CHCl3 extract was injected onto a
column (3.2 mm by 3.1 m) of 25% polyethylene glycol 1500, Chromosorb W 60/80 AW · DMCS (Shimadzu), at 50°C or a column
(3.2 mm by 2.1 m) of 15% Silicone D 200, Shimalite F 40/60
(Shimadzu), heated at 100°C. The column was eluted with
N2 gas at a flow rate of 60 ml/min. The solvent was
detected with a flame ionization detector.
Protein content.
Protein content was measured by the method
of Lowry et al. (13).
DNA manipulation.
DNA manipulations, including preparation
of plasmid DNA, agarose gel electrophoresis, restriction enzyme
digestion, ligation, and transformation of E. coli cells,
were carried out by standard methods.
Cloning of genes acrAB, emrAB, and
yhiUV.
The region containing acrAB was amplified
by PCR using W3110 chromosomal DNA as the template. The
emrAB and yhiUV operons were cloned from JA300,
also by PCR. The primers used were designed according to the sequence
deposited in GenBank (accession numbers: acrAB, AE000152;
emrAB, AE000353; and yhiUV, AE000427) as follows:
a forward primer for acrAB,
5'-CGGTCATAACTTTCCAGACAGAGA-3' (537 to 560 bp upstream of
the initiation codon of acrA); a reverse primer for
acrAB, 5'-AAAACTTACTGACCTGGACTTGCC-3' (471 to 494 bp downstream of the stop codon of acrB); a forward primer
for emrAB, 5'-AGCGGATCCGTCATCTCGCTCAA-3'
(110 to 132 bp upstream of the initiation codon of
emrA); a reverse primer for emrAB,
5'-CAGGAATTCATATGAGTCTGATTGGTACG-3' (298 to 326 bp downstream of the stop codon of emrB); a forward primer
for yhiUV, 5'-AGTAGAATTCTTCGTTGCCCGAAT-3'
(189 to 210 bp upstream of the initiation codon of
yhiU); and a reverse primer for yhiUV,
5'-ATTGGATCCTGAATGGTTAGCAGGAAA-3' (46 to 72 bp
downstream of the stop codon of yhiV). The underline shows
the EcoRI or BamHI site introduced into each
primer. A 4.4-kb XhoI-EcoT22I fragment containing
the acrAB genes, a 3.2-kb BamHI-EcoRI
fragment containing the emrAB genes, and a 4.6-kb
BamHI-EcoRI fragment containing the
yhiUV genes were obtained from the amplified products. The fragment containing the acrAB genes was inserted into the
XhoI-PstI sites of vector pBluescript II KS(+).
The cloned genes were recovered by XhoI-BamHI
digestion of pAcrAB4 and inserted into the
SalI-BamHI sites of vector pMW219. The
BamHI-EcoRI fragment containing the emrAB genes and that containing the yhiUV genes
were inserted into the BamHI-EcoRI sites of
vector pMW219 and pMW218, respectively.
Disruption of the acrAB genes in JA300.
A
Kanr cassette isolated by PstI digestion of
pUC4K and vector pG+host4 digested with SacI
were blunted and ligated. The resulting plasmid pGK619 is a
pG+host4 derivative containing kan instead of
erm. Plasmid pAcrAB4 was digested with BsmI and
HpaI to obtain a truncated 2.6-kb fragment extending from
the 156th codon of acrA to the 612th codon of
acrB. This fragment was ligated with a cat gene
isolated from pHSG399 digested with AccII. The resulting
plasmid p
AcrAB::cat is a pBluescript II KS(+)
derivative containing the N-terminal region of acrA, a
cat gene, and the C-terminal region of acrB
tandemly. A part of this insert was amplified by PCR with
p
AcrAB::cat DNA as the template. The primers
used were designed according to the deposited sequence as follows: a
forward primer, 5'-GTGAATTCAAACAGGCCCAACAAG-3' (corresponding to the 25th to 33rd codons of acrA),
and a reverse primer, 5'-GGAAGGGCCCGTCATTGGTCAGGCCA-3'
(complementary to the 920th to 928th codons of acrB).
The primer sequence was designed to contain an EcoRI or
ApaI site, shown by the underlines. The amplified product
was digested with EcoRI and ApaI and inserted into the sites of pGK619. The resulting plasmid pGK914 is a
kanamycin-resistant pG+host4 derivative containing 385 bp
of the central region of acrA, 1,057 bp of cat,
and 937 bp of the central region of acrB.
JA300(pGK914) cells were resistant to chloramphenicol and kanamycin at
28°C but not at 42°C. Clones showing the resistance also at 42°C
occurred at a low frequency in the JA300(pGK914) culture. These clones
were candidates of cells in which pGK914 DNA was first inserted into
the chromosome by a crossover event. Clones that were resistant to
chloramphenicol (6.3 µg/ml) but sensitive to kanamycin (25 µg/ml)
were obtained from one of the candidate clones.
The region containing acrAB was amplified by PCR using
chromosomal DNA from one of the chloramphenicol-resistant and
kanamycin-sensitive clones as the template. The primers used were the
same as those used to construct pGK914 from
p
AcrAB::cat. Consistent with the expected
values, the size of the amplified product from JA300 was 3.9 kb and
those from JA300A and JA300TA were 2.4 kb. This acrAB
disruptant was named JA300A. JA300TA, a tolC and
acrAB disruptant, was constructed from JA300T(pGK914) in the
same manner. It was confirmed that neither JA300A nor JA300TA produced
a protein reactive with antiserum against AcrA (results not shown).
Materials.
The organic solvents used were of the highest
quality available (Wako Pure Chemical Industries, Osaka, Japan).
Antiserum against AcrA was a kind gift from H. Nikaido of the
University of California, Berkeley. The
emrB::kan disruptant OLS111 was kindly
provided by A. Xiong and A. Matin of Stanford University.
 |
RESULTS |
Important contribution of acrAB and tolC to
maintaining intrinsic solvent resistance of E. coli.
It has
been reported that the acrAB genes are involved in the
resistance of E. coli to n-hexane and cyclohexane
(25). We found that tolC mutants are
hypersensitive to various solvents, including n-hexane and
cyclohexane (4). TolC protein functions as an outer membrane
channel of efflux pumps, including the AcrAB system (5). To
examine the role of the AcrAB-TolC efflux pump system in the
solvent resistance mechanism of E. coli, the
resistance of
acrAB and/or
tolC mutants
was assessed by testing for growth on LBGMg agar overlaid with
the individual solvents (Table 2).
JA300 grew on the agar medium overlaid with any one of the solvents
with a log POW value greater than or equal to
3.9. JA300T and JA300TA grew only on the agar overlaid with decane.
JA300A grew in the presence of decane or nonane, although the number of
colonies formed in the presence of nonane was low. Thus, the solvent
resistance levels of these mutants were almost the same, but the
tolC mutants were slightly more sensitive to nonane than the
acrAB mutant.
The mutants were transformed with a plasmid containing acrAB
or tolC under the control of Plac. JA300A became
as resistant to solvents as the parent upon introduction of
acrAB. Addition of IPTG
(isopropyl-
-D-thiogalactopyranoside) improved the
solvent resistance of JA300(pLKAcrAB) and that of
JA300A(pLKAcrAB). On the other hand, the effect of
tolC expression on solvent resistance was complicated.
JA300T became as resistant to solvents as the parent by introduction of
tolC. JA300T(pLTolC) was as resistant to solvent as
JA300 in the presence and absence of IPTG. However, introduction of
tolC into JA300A lowered the nonane resistance. JA300A(pLTolC) became sensitive to nonane in the presence
of IPTG. These results suggest that the TolC channel overproduced in
the absence of AcrAB allows entry of nonane from the external milieu. In the case of JA300TA, weak nonane resistance was restored by introduction of tolC but not acrAB.
Overexpression of tolC in the presence of IPTG made
JA300TA(pLTolC) sensitive to nonane. Thus,
JA300TA(pLTolC) was as resistant to nonane as
JA300A(pLTolC). The n-hexane resistance in JA300TA
was restored only upon introduction of both genes, acrAB and
tolC, although JA300TA(pLKAcrAB and pLTolC) was more
sensitive to n-hexane or heptane than JA300. The resistance of this transformant to heptane or n-hexane was improved in
the presence of IPTG. Thus, AcrAB and TolC are essential for
E. coli to grow in the presence of a large volume of
weakly harmful solvent, as reported previously (4, 25). It
is evident that the AcrAB-TolC pump is the main system responsible for
maintaining resistance to several solvents. However, it is likely that
unidentified transporter systems depending on TolC confer weak nonane
resistance on E. coli.
Putative contribution of genes encoding transporter systems to
resistance to low-toxicity solvents in the acrAB mutant.
E. coli has several genes encoding putative or proven
multidrug transporters (16, 20). Among them, the
emrAB and yhiUV operons were cloned
from the JA300 chromosome and inserted into a low-copy-number vector
under the control of Plac. The nonane resistance of JA300A
was improved by an increase in the copy number of emrAB or
yhiUV (Table 3). In addition,
JA300A acquired octane resistance upon introduction of these
operons. The octane resistance was improved when expression of
the operons contained in the plasmids was elevated in the
presence of IPTG. The solvent resistance of JA300T was not improved
upon introduction of the cloned operons (results not shown).
These results indicate the operons conferred resistance to
these weakly toxic solvents on E. coli, depending on
TolC when overexpressed.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Improvement of the organic solvent tolerance level of an
acrAB mutant by an increase in the copy number of
genes encoding transporters
|
|
The Emr transporter system is known to extrude various drugs
(12). To examine the contribution of the Emr transporter
system encoded on the chromosome to solvent resistance, the
emrB genes in JA300 and JA300A were disrupted by P1
transduction of emrB::kan from OLS111.
The resulting emrB disruptants, JA300E and JA300AE, were as
resistant to solvents as JA300 and JA300A, respectively (results
not shown). These findings suggest that the nonane resistance observed in the case of the
acrAB mutant was not mediated
only by the emr operon. Probably, several
transporters are required to confer the nonane resistance on JA300A.
Entry of organic solvent into the E. coli tolC
mutant in a two-phase culture system.
We previously observed that
E. coli cells accumulate solvent in a two-phase culture
system (2). E. coli cells possessing the
AcrAB-TolC efflux pump system were used at that time. Results shown in
Tables 2 and 3 suggest that solvent efflux from the cells occurs
through TolC-dependent systems. In this study, we measured solvent
entry into an E. coli
tolC mutant to avoid
interference by the solvent efflux systems. The increase in the
intracellular solvent level (Cc) was
followed by measuring Cc periodically
after the addition of each test solvent (10% [vol/vol]) to a culture of JA300 or JA300T in the late exponential phase of growth. Highly toxic solvents, such as toluene or p-xylene, rapidly entered
the JA300T cells (Fig. 1). Weakly toxic solvents, such as nonane, entered the cells slowly. The initial rate of solvent entry and Cc after incubation with the solvent were
correlated inversely with the log POW of the
solvent in the two-phase culture system.
Also in the case of JA300, the initial rate of solvent entry and
Cc were correlated inversely with the log
POW of the solvent. Cyclohexane entered the
JA300 cells as rapidly as in the case of JA300T cells.
n-Hexane, heptane, and octane entered the JA300 cells more
slowly than in the case of JA300T cells. In particular, the
Cc of heptane and that of octane were maintained
at near-constant levels in JA300 cells, even after 60 min. These
results indicate that a TolC-dependent transporter system contributed
to keeping the Cc of heptane and octane at a low
level, but not that of cyclohexane. These results were consistent with
the observation that JA300 was resistant to heptane and sensitive to
cyclohexane. The n-hexane resistance of JA300 depends on the
culture conditions (3). It is clear that E. coli remains heptane resistant by keeping the
Cc of heptane low.
Accumulation of organic solvent in E. coli
incubated in a two-phase culture system.
To assess the relative
contribution of AcrAB and TolC to solvent resistance, we measured
Cc in JA300, JA300A, and JA300T cells incubated
in a two-phase system. Figure 1 shows
that the Cc of each solvent was dependent on the
incubation period. In particular, the entry of nonane was slow. Here,
we show the Cc values obtained after exposure to
each solvent for 30 min. Figure 2 shows
the Cc of nonane or decane as measured 4 h
after addition of the solvent. In addition, the figure shows the
viability of the cells at the time when the Cc
was determined.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
Entry of solvent into E. coli cells.
JA300T (A) and JA300 (B) were each grown in 200 ml of LBGMg medium in a
2,000-ml Erlenmeyer flask rotated at 120 rpm. The cells in the late
exponential phase (OD660, 1.5 to 2.0) were harvested by
centrifugation (24°C, 4,000 × g, 6 min) and
suspended in 25 ml of the medium. The suspension (5 ml) and 35 ml of
the medium containing 4 ml of solvent were mixed in a 200-ml Erlenmeyer
flask. The suspension was shaken at 160 rpm. Periodically, a portion of
the culture was withdrawn and centrifuged (15°C, 6,000 × g, 1 min). The cells were suspended in 0.9% NaCl-10 mM
MgSO4. The suspension was extracted with CHCl3,
and the amount of solvent in the CHCl3 extract was
measured. Each value shown is the mean value for two or three
measurements. Symbols: , p-xylene; , cyclohexane; ,
n-hexane; ; heptane; , octane; , nonane.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 2.
Accumulation of solvents in E. coli
cells in a two-phase culture system. JA300 (circles), JA300T (squares),
and JA300A (triangles) were grown in LBGMg medium and exposed to
solvent in the two-phase system, as described in the legend for Fig. 1.
The solvents tested were toluene (log POW = 2.64) and p-xylene (log POW = 3.14) in addition to those shown in Table 2. The suspension was shaken
at 160 rpm. A portion of the culture was centrifuged (15°C,
6,000 × g, 1 min) after 30 min. The amount of solvent
accumulated in the cells was measured, as described in Fig. 1. A sample
was also taken 4 h after the addition of n-nonane or
n-decane in the case of JA300T (the result at 4 h is
shown by a broken line). Each value shown is the mean value for three
measurements. The viability of the cells was examined by plating a
portion of the culture on LBGMg agar. The frequency of survivors is
indicated by the following symbols: open symbol, less than
10 6; dotted symbol, 10 4; solid symbol, 1. The solubilities of these solvents in water, determined at 37°C, were
5.3, 1.4, 0.68, 0.21, 0.064, 0.034, and 0.0071 mM for toluene,
p-xylene, cyclohexane, n-hexane, heptane, octane,
and nonane, respectively. The solubility of decane was not determined
because of its low solubility.
|
|
There was no difference in the Cc of toluene,
p-xylene, or cyclohexane among the strains. All of the cells
were killed within 30 min upon exposure to these solvents. When
exposed to n-hexane, heptane, or octane, the
Cc of each solvent was higher in JA300A and
JA300T than that found in JA300. JA300A and JA300T accumulated the same
Cc of each solvent. JA300A and JA300T were also
killed in the presence of these solvents. When exposed to nonane or
decane, the Cc of each of the two solvents was
almost the same in JA300A and JA300T after 30 min. At this time,
both strains were viable. The Cc of nonane or
decane increased substantially in JA300T but only slightly in the other
strains. After 4 h, nonane killed only JA300T, not the other
strains. It can be concluded that the AcrAB-TolC pump is
essential to reduce the Cc of
n-hexane, heptane, or octane in E. coli
cells exposed to these solvents. The Cc of
nonane and that of decane are likely to be lowered partially by some
TolC-dependent efflux system other than AcrAB-TolC. It is interesting
that JA300A exposed to nonane or decane showed a lower
Cc than that observed in JA300T. This is
consistent with the finding that JA300T and JA300TA were more sensitive
to nonane than JA300A (Table 2). These results support the view that in
E. coli, efflux of nonane and decane also occurs via
some TolC-dependent system other than AcrAB.
JA300T was killed by exposure to the solvents shown in Fig. 2, except
for decane. Regardless of the difference among the strains, E. coli cells killed by exposure to the solvents showed
a similar Cc for each solvent in the two-phase
system. The Cc of solvents with a log
POW in the range of 2.6 to 5.5 is given by the
following equation: log Cc = 1.38
0.37 × log POW. This equation represents the solvent accumulation in E. coli cells killed upon
exposure to a large volume of solvent in a two-phase system. On the
other hand, almost all JA300 cells maintained viability in the
two-phase system containing any solvent with a log
POW in the range of 4.4 to 6.0. Cc corresponding to the linear part of the
solvent accumulation curve for JA300 was lower than that found for
JA300T exposed to such solvents. This part of the curve is given by the
following equation: log Cc = 1.76
0.65 × log POW. This equation represents the solvent accumulation in viable JA300 cells growing in a two-phase system.
Release of intracellular organic solvents from E. coli cells.
Solvents probably diffuse into E. coli cells by partitioning between the cells and their external
milieu. Therefore, the cells that had accumulated a solvent would
release the solvent upon lowering the solvent concentration in the
medium. It was supposed that the solvent would be released from the
cells by passive diffusion and through the action of the solvent efflux pump.
To observe the solvent efflux process, cells loaded with solvent were
incubated in medium containing no solvent. Cell viability was
maintained by loading the cells with the test solvent at a low
Cc (0.01 to 0.1 µmol/mg of protein). It is
reported that the Cc of a solvent is correlated
with the concentration of the solvent in the medium (19).
Cells loaded with solvent at a low Cc were prepared by incubation with a low concentration of the solvent. No
strain was killed by the test solvent under these conditions. Release
of the intracellular solvent from the cells was followed by periodic
determination of Cc. Figure
3 shows typical examples of the release
of n-hexane or heptane from JA300, JA300A, JA300T, and
JA300(pLKAcrAB). It seems likely that each intracellular solvent was released from all strains through a first-order reaction, at least
in the initial period. Assuming that the solvent is released from
each cell by passive diffusion and active extrusion through a
first-order reaction, the rate constants for the release of intracellular solvents were calculated for the viable cells (Table 4).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Release of intracellular solvent from E. coli cells. JA300 ( ), JA300T ( ), JA300A ( ), and
JA300(pLKAcrAB) ( ) were loaded with n-hexane (A) or
heptane (B), as described in the legend for Fig. 1. After incubation
with the solvent for 30 min, the cell suspension (40 ml) was
centrifuged (24°C, 6,000 × g, 1 min). The cells were
suspended in 20 ml of LBGMg medium in a 50-ml Erlenmeyer flask and
incubated at 37°C with shaking at 160 rpm. Time zero represents the
time at which the cells were suspended in fresh medium. A portion of
the cell suspension (2 ml) was withdrawn periodically and centrifuged
(15°C, 6,000 × g, 1 min) at the times shown. The
solvent in the cells was measured as described in the legend for Fig.
1. Solid and broken lines indicate the release of each solvent from
cells in which Cc was low and high,
respectively. The initial Cc was controlled by
altering the volume of solvent added, as follows: for
n-hexane, JA300, 0.2 or 4 ml; JA300T, 0.2 or 4 ml; JA300A,
0.2 ml; and JA300(pLKAcrAB), 0.25 ml; for heptane, JA300, 2 ml;
JA300T, 0.1 or 2 ml; and JA300A, 2 ml. Each value shown is a typical
example.
|
|
The rate constant for each solvent was the highest in the case of JA300
and the lowest in the case of JA300T, among the cells loaded with
solvent at low Cc. However, solvent release
seemed to be retarded when the cells were loaded with solvent at high Cc. This retardation was clearly evident in the
case of JA300 loaded with n-hexane loaded up to the level of
0.4 µmol/mg of protein, but not in the case of JA300T (Fig. 3A).
Consequently, n-hexane was released at similar rates from
JA300 and JA300T when the initial Cc of
n-hexane was high. The membrane structure of JA300 is
disordered under the conditions employed (3). Probably, the
activity of RND family efflux pumps is lowered in the structurally disordered membrane. Therefore, as described below, we evaluated the
relative contribution of AcrAB and TolC to solvent release on the basis
of the results obtained with viable cells.
The rate constant for TolC-independent solvent release found in the
case of JA300T was inversely dependent on the log
POW of the solvent. The difference in the rate
constants for release of the solvents among the strains is likely
attributable to the difference in solvent efflux activity. The rate
constants for solvent release via TolC were estimated by comparison of
the rate constants found for JA300 and JA300T, as follows: nonane,
0.06/min; octane, 0.16/min; heptane, 0.17/min; hexane, 0.19/min; and
cyclohexane, 0.07/min. The rate constants for solvent release via
AcrAB were calculated as follows: nonane, 0.05/min; octane, 0.15/min;
heptane, 0.16/min; and hexane, 0.13/min. Determining the solvent
release rate revealed that AcrAB extrudes heptane most preferentially among the solvents tested. The rate constants for release of hexane and
cyclohexane were improved by an increase in the copy number of
acrAB, indicating that the AcrAB transporter indeed extrudes these solvents from E. coli cells.
 |
DISCUSSION |
Since a toluene-resistant strain of Pseudomonas putida
was isolated (6), various mechanisms have been proposed to
account for the solvent resistance of microbes. It has been shown that efflux pumps belonging to the RND family are important for solvent resistance in gram-negative bacteria (4, 8, 21, 25). The
AcrAB-TolC efflux pump is involved in the solvent resistance of
E. coli. We are interested in culturing microbes in a
two-phase system containing a large volume of solvent. Our findings
concerning solvent resistance, examined in the presence of a large
volume of each solvent (Table 2), confirmed that the genes
acrAB and tolC are essential to maintain the
intrinsic level of resistance of E. coli to hydrophobic
solvents, although it has been proposed that AcrAB functions
preferentially in efflux of amphiphilic charged compounds
(16). It is reported that tolC mutants are more
sensitive to various antibiotics than acrAB mutants
(5). Certain transporters other than AcrAB confer weak
solvent resistance to E. coli (Tables 2 and 3),
although we failed to identify the transporter.
Resistance to solvents with a log POW in the
range of 3.9 to 5.5 is conferred on E. coli incubated
in a two-phase culture system by the AcrAB-TolC pump encoded on the
chromosome. Under these conditions, accumulation of solvents with a log
POW in the range of 4.4 to 5.9 was reduced to a
level one-sixth to one-tenth of that observed in the case of
acrAB or tolC mutants (Fig. 1 and 2).
n-Hexane (log POW, 3.9) is subtoxic
to JA300 in the two-phase culture system.
The more polar solvents were more preferentially released by the
TolC-independent process (Table 4),
suggesting that this process involves passive diffusion of the solvent
in response to the solubility of the solvent in the medium. Therefore,
it is likely that the TolC-independent solvent release process does not
occur substantially when the medium is saturated with the solvent in
the presence of a large volume of the pure solvent. Alternatively, the
solvent might be extruded by a TolC-independent process, although this
possibility is not supported by the results of genetic analysis of
solvent resistance (Table 2). The TolC-dependent process released
octane, heptane, and n-hexane preferentially. These two
solvent release processes differ in terms of solvent specificity. The
AcrAB-dependent extrusion was responsible for the major portion of the
TolC-dependent solvent release. A portion of the solvents is likely
released through the TolC channel without any involvement of AcrAB. It
is not likely that there is an AcrAB-dependent and TolC-independent
process, considering that solvent accumulation was similar between
JA300T and JA300TA.
In this study, we examined the features of solvent entry into
E. coli cells containing no solvent and solvent release
into the external milieu containing no solvent. It may be assumed that the influx and efflux of solvent are probably balanced in microbes growing in a two-phase culture system. We could not measure the rates
of influx and efflux separately in the two-phase system. However, the
Ccs of heptane, octane, nonane, and decane were
maintained at low levels in JA300 (Fig. 2). We showed that the
Cc of octane and that of heptane were constant
(0.04 and 0.08 µmol/mg of protein, respectively) in JA300 for 60 min
(Fig. 1), indicating that the influx and efflux of heptane or octane
were balanced in JA300 incubated in the two-phase system.
n-Hexane entered JA300 cells more slowly than it entered
JA300T cells, although the rate increased gradually during the
incubation period. The n-hexane resistance of JA300 is
lowered at high cell density, probably because of a shortage of oxygen
(17). It is supposed that influx and efflux of
n-hexane are probably balanced in JA300 at low cell density in the two-phase system containing n-hexane (3).
On the other hand, the activity of the AcrAB-TolC system in JA300 was
insufficient to extrude cyclohexane from the cells in the two-phase
system (Fig. 1). This is probably because of low activity, rather than the substrate specificity, because introduction of pLKAcrAB resulted in
increased cyclohexane release from JA300 cells (Table 4).
It is reported that entry of toluene into P. putida S12 is
lowered by some active efflux system (7). In that study,
solvent entry was examined in a medium containing toluene below the
saturation concentration. The reported Cc of
toluene in P. putida S12 cells in which energy
production was inhibited is one-tenth of that found in E. coli exposed to a large volume of toluene in this study. P. putida S12 might have an additional resistance mechanism to
toluene other than the efflux system. Genes srpABC involved in toluene efflux have been cloned from P. putida S12. As a
result of transformation with these genes, P. putida
tolerant to 2.6 mM toluene became tolerant to 4.9 mM but not 5.6 mM
toluene (8). The transformant cannot grow in a two-phase
system containing toluene. Thus, the toxicity of the solvent is greatly
dependent on the concentration. When JA300 was incubated in the
presence of cyclohexane or p-xylene, the cell viability was
dependent on the concentration of the solvent present (results not
shown). Solvent entry is dependent on the concentration of the solvent in the medium (19). In this study, solvent entry was
examined in E. coli cells incubated in a two-phase
system. Therefore, the results described here show the features of
solvent accumulation by E. coli cells in a two-phase
system containing a large volume of solvent.
 |
ACKNOWLEDGMENTS |
This work was partially supported by a Grant-in-Aid for
Scientific Research (no. 10450308) from the Ministry of Science,
Education and Culture of Japan to R. Aono.
We thank H. Asako for his assistance. We thank H. Nikaido of the
University of California, Berkeley, for the kind gift of antiserum
against AcrA. We also thank A. Xiong and A. Matin of Stanford
University for kindly providing the
emrB::kan disruptant OLS111.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biological Information, Graduate School of Bioscience and
Biotechnology, Tokyo Institute of Technology, Nagatsuta 4259, Midori-ku, Yokohama 226-8501, Japan. Phone: (81) 45-924-5766. Fax: (81)
45-924-5819. E-mail: raono{at}bio.titech.ac.jp.
 |
REFERENCES |
| 1.
|
Aono, R.,
K. Aibe,
A. Inoue, and K. Horikoshi.
1991.
Preparation of organic solvent tolerant mutants from Escherichia coli K-12.
Agric. Biol. Chem.
55:1935-1938.
|
| 2.
|
Aono, R., and H. Kobayashi.
1997.
Cell surface properties of organic solvent-tolerant mutants of Escherichia coli K-12.
Appl. Environ. Microbiol.
63:3637-3642[Abstract].
|
| 3.
|
Aono, R.,
H. Kobayashi,
K. N. Joblin, and K. Horikoshi.
1994.
Effects of organic solvents on growth of Escherichia coli K-12.
Biosci. Biotechnol. Biochem.
58:2009-2014.
|
| 4.
|
Aono, R.,
N. Tsukagoshi, and M. Yamamoto.
1998.
Involvement of outer membrane protein TolC, a possible member of the mar-sox regulon, in maintenance and improvement of organic solvent tolerance of Escherichia coli K-12.
J. Bacteriol.
180:938-944[Abstract/Free Full Text].
|
| 5.
|
Fralick, J. A.
1996.
Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli.
J. Bacteriol.
178:5803-5805[Abstract/Free Full Text].
|
| 6.
|
Inoue, A., and K. Horikoshi.
1989.
A Pseudomonas thrives in high concentrations of toluene.
Nature
338:264-265[CrossRef].
|
| 7.
|
Isken, S., and J. A. M. de Bont.
1996.
Active efflux of toluene in a solvent-tolerant bacterium.
J. Bacteriol.
178:6056-6058[Abstract/Free Full Text].
|
| 8.
|
Kieboom, J.,
J. J. Dennis,
J. A. M. de Bont, and G. J. Zylstra.
1998.
Identification and molecular characterization of an efflux pump involved in Pseudomonas putida S12 solvent tolerance.
J. Biol. Chem.
273:85-91[Abstract/Free Full Text].
|
| 9.
|
Kohara, Y.,
K. Akiyama, and K. Isono.
1987.
The physical map of the whole E. coli chromosome: application of a new strategy for rapid analysis and sorting of a large genomic library.
Cell
50:495-508[CrossRef][Medline].
|
| 10.
|
Leo, A. J.
1993.
Calculating log POW from structures.
Chem. Rev.
93:1281-1306[CrossRef].
|
| 11.
|
Li, X.-Z.,
Z. Li, and K. Poole.
1998.
Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance.
J. Bacteriol.
180:2987-2991[Abstract/Free Full Text].
|
| 12.
|
Lomovskaya, O., and K. Lewis.
1992.
emr, an Escherichia coli locus for multidrug resistance.
Proc. Natl. Acad. Sci. USA
89:8938-8942[Abstract/Free Full Text].
|
| 13.
|
Lowry, O. H.,
N. J. Rosebrough,
A. L. Farr, and R. J. Randall.
1951.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem.
193:265-275[Free Full Text].
|
| 14.
|
Ma, D.,
D. N. Cook,
M. Alberti,
N. G. Pon,
H. Nikaido, and J. E. Hearst.
1995.
Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli.
Mol. Microbiol.
16:45-55[CrossRef][Medline].
|
| 15.
|
Machleidt, H.,
S. Roth, and P. Seeman.
1972.
The hydrophobic expansion of erythrocyte membranes by the phenol anesthetics.
Biochim. Biophys. Acta
255:178-189[Medline].
|
| 16.
|
Nikaido, H.
1996.
Multidrug efflux pumps of gram-negative bacteria.
J. Bacteriol.
178:5853-5859[Free Full Text].
|
| 17.
|
Noguchi, K.,
H. Nakajima, and R. Aono.
1997.
Effects of oxygen and nitrate on growth of Escherichia coli and Pseudomonas aeruginosa in the presence of organic solvents.
Extremophiles
1:193-198[CrossRef][Medline].
|
| 18.
|
Noguchi, K.,
N. Tsukagoshi, and R. Aono.
1999.
Deterioration of tolerance to hydrophobic organic solvents in a toluene-tolerant strain of Pseudomonas putida under the conditions lowering aerobic respiration.
Biosci. Biotechnol. Biochem.
63:1400-1406[CrossRef].
|
| 19.
|
Osborne, S. J.,
J. Leaver,
M. K. Turner, and P. Dunnill.
1990.
Correlation of biocatalytic activity in an organic-aqueous two-liquid phase system with solvent concentration in the cell membrane.
Enzyme Microb. Technol.
12:281-291[CrossRef][Medline].
|
| 20.
|
Paulsen, I. T.,
M. H. Brown, and R. A. Skurray.
1996.
Proton-dependent multidrug efflux systems.
Microbiol. Rev.
60:575-608[Abstract/Free Full Text].
|
| 21.
|
Ramos, J. L.,
E. Duque,
P. Godoy, and A. Segura.
1998.
Efflux pumps involved in toluene tolerance in Pseudomonas putida DOT-T1E.
J. Bacteriol.
180:3323-3329[Abstract/Free Full Text].
|
| 22.
|
Ramos, J. L.,
E. Duque,
J. J. RodriguezHerva,
P. Godoy,
A. Haidour,
F. Reyes, and A. FernandezBarrero.
1997.
Mechanisms for solvent tolerance in bacteria.
J. Biol. Chem.
272:3887-3890[Abstract/Free Full Text].
|
| 23.
|
Sikkema, J.,
J. A. M. de Bont, and B. Poolman.
1994.
Intercalations of cyclic hydrocarbons with biological membranes.
J. Biol. Chem.
269:8022-8028[Abstract/Free Full Text].
|
| 24.
|
Sikkema, J.,
J. A. M. de Bont, and B. Poolman.
1995.
Mechanisms of membrane toxicity of hydrocarbons.
Microbiol. Rev.
59:201-222[Abstract/Free Full Text].
|
| 25.
|
White, D. G.,
J. D. Goldman,
B. Demple, and S. B. Levy.
1997.
Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli.
J. Bacteriol.
179:6122-6126[Abstract/Free Full Text].
|
Journal of Bacteriology, September 2000, p. 4803-4810, Vol. 182, No. 17
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Shimizu, K., Hayashi, S., Kako, T., Suzuki, M., Tsukagoshi, N., Doukyu, N., Kobayashi, T., Honda, H.
(2005). Discovery of glpC, an Organic Solvent Tolerance-Related Gene in Escherichia coli, Using Gene Expression Profiles from DNA Microarrays. Appl. Environ. Microbiol.
71: 1093-1096
[Abstract]
[Full Text]
-
Vijayakumar, S. R. V., Kirchhof, M. G., Patten, C. L., Schellhorn, H. E.
(2004). RpoS-Regulated Genes of Escherichia coli Identified by Random lacZ Fusion Mutagenesis. J. Bacteriol.
186: 8499-8507
[Abstract]
[Full Text]
-
Yu, E. W., Aires, J. R., Nikaido, H.
(2003). AcrB Multidrug Efflux Pump of Escherichia coli: Composite Substrate-Binding Cavity of Exceptional Flexibility Generates Its Extremely Wide Substrate Specificity. J. Bacteriol.
185: 5657-5664
[Full Text]
-
Eguchi, Y., Oshima, T., Mori, H., Aono, R., Yamamoto, K., Ishihama, A., Utsumi, R.
(2003). Transcriptional regulation of drug efflux genes by EvgAS, a two-component system in Escherichia coli. Microbiology
149: 2819-2828
[Abstract]
[Full Text]
-
Abe, S., Okutsu, T., Nakajima, H., Kakuda, N., Ohtsu, I., Aono, R.
(2003). n-Hexane sensitivity of Escherichia coli due to low expression of imp/ostA encoding an 87 kDa minor protein associated with the outer membrane. Microbiology
149: 1265-1273
[Abstract]
[Full Text]
-
Shyu, J. B. H., Lies, D. P., Newman, D. K.
(2002). Protective Role of tolC in Efflux of the Electron Shuttle Anthraquinone-2,6-Disulfonate. J. Bacteriol.
184: 1806-1810
[Abstract]
[Full Text]
-
Nishino, K., Yamaguchi, A.
(2001). Analysis of a Complete Library of Putative Drug Transporter Genes in Escherichia coli. J. Bacteriol.
183: 5803-5812
[Abstract]
[Full Text]
-
Rojas, A., Duque, E., Mosqueda, G., Golden, G., Hurtado, A., Ramos, J. L., Segura, A.
(2001). Three Efflux Pumps Are Required To Provide Efficient Tolerance to Toluene in Pseudomonas putida DOT-T1E. J. Bacteriol.
183: 3967-3973
[Abstract]
[Full Text]
-
Kobayashi, K., Tsukagoshi, N., Aono, R.
(2001). Suppression of Hypersensitivity of Escherichia coli acrB Mutant to Organic Solvents by Integrational Activation of the acrEF Operon with the IS1 or IS2 Element. J. Bacteriol.
183: 2646-2653
[Abstract]
[Full Text]